These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 8682023
1. Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Fosinopril Efficacy/Safety Trial (FEST) Study Group. Erhardt L, MacLean A, Ilgenfritz J, Gelperin K, Blumenthal M. Eur Heart J; 1995 Dec; 16(12):1892-9. PubMed ID: 8682023 [Abstract] [Full Text] [Related]
2. Effects of fosinopril on exercise tolerance and clinical deterioration in patients with chronic congestive heart failure not taking digitalis. Fosinopril Heart Failure Study Group. Brown EJ, Chew PH, MacLean A, Gelperin K, Ilgenfritz JP, Blumenthal M. Am J Cardiol; 1995 Mar 15; 75(8):596-600. PubMed ID: 7887385 [Abstract] [Full Text] [Related]
3. Effects of fosinopril on exercise tolerance, symptoms, and clinical outcomes in patients with decompensated heart failure. Shettigar U, Hare T, Gelperin K, Ilgenfritz JP, Deitchman D, Blumenthal M. Congest Heart Fail; 1999 Mar 15; 5(1):27-34. PubMed ID: 12189330 [Abstract] [Full Text] [Related]
4. Fosinopril. A review of its pharmacology and clinical efficacy in the management of heart failure. Davis R, Coukell A, McTavish D. Drugs; 1997 Jul 15; 54(1):103-16. PubMed ID: 9211084 [Abstract] [Full Text] [Related]
6. Plasma endothelin in congestive heart failure: effect of the ACE inhibitor, fosinopril. Galatius-Jensen S, Wroblewski H, Emmeluth C, Bie P, Haunsø S, Kastrup J. Cardiovasc Res; 1996 Dec 15; 32(6):1148-54. PubMed ID: 9015418 [Abstract] [Full Text] [Related]
7. [Head-to-head comparison of clinical, biochemical and functional effects of fosinopril and enalapril in patients with systolic heart failure]. Otasević P, Putiniković B, Vukajlović Z, Ilisić B, Nesković AN. Med Pregl; 2006 Dec 15; 59(1-2):51-6. PubMed ID: 17068892 [Abstract] [Full Text] [Related]
8. Differential effects of fosinopril and enalapril in patients with mild to moderate chronic heart failure. Fosinopril in Heart Failure Study Investigators. Zannad F, Chati Z, Guest M, Plat F. Am Heart J; 1998 Oct 15; 136(4 Pt 1):672-80. PubMed ID: 9778071 [Abstract] [Full Text] [Related]
9. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial. Rouleau JL, Pfeffer MA, Stewart DJ, Isaac D, Sestier F, Kerut EK, Porter CB, Proulx G, Qian C, Block AJ. Lancet; 2000 Aug 19; 356(9230):615-20. PubMed ID: 10968433 [Abstract] [Full Text] [Related]
15. Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group. Littler WA, Sheridan DJ. Br Heart J; 1995 May 19; 73(5):428-33. PubMed ID: 7786657 [Abstract] [Full Text] [Related]